小鼠后肢缺血模型肌肉组织中S1P相关受体基因表达的研究-东南大学学报医学版

小鼠后肢缺血模型肌肉组织中S1P相关受体基因表达的研究

单位：1. 中国医科大学附属第一医院放射科, 辽宁省影像诊断与介入治疗重点实验室, 辽宁沈阳 110001;
2. 金沢大学大学院医学部循环医科学血管分子生理学, 日本金沢 920-8640;
3. 辽宁省肿瘤医院医院感染管理办公室, 辽宁沈阳 110004

关键词：1-磷酸鞘氨醇受体基因表达血管新生血流恢复后肢缺血小鼠

分类号：R-332;R363;Q75

出版年·卷·期（页码）：2015·34·第一期（17-21）

摘要：

目的:观察不同时间点小鼠后肢缺血模型肌肉组织中S1P受体的基因表达情况,探讨其在后肢缺血模型血管新生及血流恢复中的作用。方法:将18只8~12周龄C57Bl/6J小鼠随机分为3 d组,即术后3 d组、术后7 d组及术后14 d组,每组6只。采用戊巴比妥麻醉小鼠,取仰卧位,钝性分离皮肤肌肉等外周组织后,分别结扎小鼠左后肢股动静脉及其分支后缝合,建立小鼠后肢缺血模型。分别于术后第1、3、5、7、10和14天采用激光多普勒血流分析仪观察缺血后肢血流变化情况。于术后第3、7和14天处死动物取腓肠肌组织行CD31免疫组织化学染色,计数微脉管密度,并提取腓肠肌组织中RNA,应用实时定量荧光PCR(real-time PCR) 技术测定腓肠肌组织中S1P受体的mRNA表达情况。结果:术后14 d内,缺血侧与未缺血侧血流比值及缺血侧CD31阳性染色微脉管密度随时间改变逐渐增加。术后第3天,S1P₁、S1P₂和S1P₃受体mRNA表达水平显著性增高,差异有统计学意义(P<0.05);术后第7天和第14天,S1P₂ 受体mRNA表达水平均显著地增高,差异具有统计学意义(P<0.05),而S1P₁和S1P₃受体mRNA表达水平无明显改变(P>0.05)。结论:小鼠后肢缺血后的血管新生和血流恢复情况在早期可能与S1P₁ 受体、S1P₂受体和S1P₃ 受体上调有关,随后与S1P₂ 受体上调有关。

Objective: To investigate the expression of S1P receptor mRNA level in ischemic hindlimbs of mice at different time points, in order to discuss possible effects on angiogenesis and blood flow recovery. Methods: 8-12 weeks old male C57Bl/6J mice were randomized divided into 3 groups: post-operative day 3 group, post-operative day 7 group and post-operative day 14 group, 6 mice for each group.Mice were subjected to surgical procedures to achieve unilateral hindlimb ischaemia after intraperitoneal injection of pentobarbital.In brief, following a skin incision at the left paracenter of the lower abdomen, the femoral artery, which originated from the external iliac artery and terminated to bifurcate into the saphenous and the popliteal arteries, was excised.The blood flow was observed at post-operative day 1, 3, 5, 7, 10 and 14 by laser Doppler blood flow analyzer.Ischemic tissue of calf muscle was excised at different time points for immunohistochemistry and real-time PCR to detect the capillary density and the expression of S1P receptor mRNA level.Results: The blood flow and capillary density in ischemic hindlimb were increased during the 14 days after operation.The mRNA expression of S1P₁ and S1P₃ was increased in ischemic limb muscle compared with non-ischemic limb muscle on post-operative day 3(P<0.05), and there was no significant difference of S1P₁ and S1P₃ between ischemic hind limbs and non-ischemic hindlimbs on the post-operative day 7 and post-operative day 14(P>0.05). There was significant difference of S1P₂ mRNA level between ischemic hind limbs and non-ischemic hindlimbs on the post-operative day 3, 7 and 14(P<0.05.Conclusion: The mRNA expressions of S1P₁, S1P₂ and S1P₃ increase in the early time phase, and only S1P₂ later in ischemic hindlimbs for angiogenesis and blood flow recovery.

参考文献：

[1] OURIEL K.Peripheral arterial disease[J].Lancet,2001,358(9289):1257-1264.
[2] FERNANDEZ B B Jr.A rational approach to diagnosis and treatment of intermittent claudication[J].Am J Med Sci,2002,323(5):244-251.
[3] TAKUWA Y,OKAMOTO Y,YOSHIOKA K,et al.Sphingosine-1-phosphate signaling in physiology and diseases[J].Biofactors,2012,38(5):329-337.
[4] 顾钰霞,刘乃丰.内皮祖细胞在冠状动脉粥样硬化性心脏病中的作用研究进展[J].东南大学学报:医学版,2014,33(3):354-358.
[5] SINGLETON P A,DUDEK S M,CHIANG E T,et al.Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor,PI3 kinase,Tiam1/Rac1,and alpha-actinin[J].FASEB J,2005,19(12):1646-1656.
[6] LEE J F,ZENG Q,OZAKI H,et al.Dual roles of tight junction-associated protein,zonula occludens-1,in sphingosine 1-phosphate-mediated endothelial chemotaxis and barrier integrity[J].J Biol Chem,2006,281(39):29190-29200.
[7] ALLENDE M L,YAMASHITA T,PROIA R L.G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation[J].Blood,2003,102(10):3665-3667.
[8] MIZUGISHI K,YAMASHITA T,OLIVERA A,et al.Essential role for sphingosine kinases in neural and vascular development[J].Mol Cell Biol,2005,25(24):11113-11121.
[9] LEE M J,THANGADA S,CLAFFEY K P,et al.Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate[J].Cell,1999,99(3):301-312.
[10] RYU Y,TAKUWA N,SUGIMOTO N,et al.Sphingosine-1-phosphate,a platelet-derived lysophospholipid mediator,negatively regulates cellular Rac activity and cell migration in vascular smooth muscle cells[J].Circ Res,2002,90(3):325-332.
[11] KIMURA T,WATANABE T,SATO K,et al.Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors,Edg-1 and Edg-3[J].Biochem J,2000,348(Pt 1):71-76.
[12] KLUK M J,HLA T.Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors[J].Biochim Biophys Acta,2002,1582(1-3):72-80.
[13] MORRIS A J,PANCHATCHARAM M,CHENG H Y,et al.Regulation of blood and vascular cell function by bioactive lysophospholipids[J].J Thromb Haemost,2009,7 (Suppl 1):38-43.
[14] 潘武,骆晓梅,徐正元,等.黄蜀葵花总黄酮对人脐静脉血管内皮细胞凋亡及fas 蛋白表达的影响[J].现代医学,2012,40(3):251-254.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录